News

The UK government has announced the formation of two further Enterprise Capital Funds, one more than it intended to set up in the first phase of the programme.

Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.

Civo BioScreening is looking for strategic partnerships to help it take forward its novel polymer screening technology.

Novartis’s move to take over UK biotech NeuTec Pharma at a large premium highlights how the so-called “superbugs” have reinvigorated pharma’s interest in antibiotics.

With the end of easy oil, French oil services giant Schlumberger Clamart Technology Centre is transforming its research and development activities.

York University's Centre for Novel Agricultural Products has won a grant from the Bill & Melinda Gates Foundation to complete research into an antimalarial plant.

Funds should start flowing at the start of 2007 in the €50 billion Framework Programme 7 after the European Parliament approved the budget.

Economic disparity across Europe's regions can be linked directly to investment in research and development and adoption of information technologies, says an official report.

The Cambridge-MIT Institute has spun out its Communications Research Network project as a company to step up the pace of innovation in communications.